Michael Shiue

Michael Shiue is an experienced professional in the field of pharmaceutical sciences with a focus on ophthalmic development. Currently serving as President of iNetX Corporation since 2018, Michael leads a consulting firm that specializes in nonclinical DMPK and ADME strategies and clinical trial data generation. In addition, as a Senior Consultant at Atheln, Inc. since 2020, Michael contributes expertise in nonclinical ocular and systemic pharmacokinetics and ADME, supporting product development strategies for pharmaceutical and biotech clients. Prior experience includes roles as a Senior Principal Scientist at Pfizer from 2008 to 2018 and as a Senior Scientist and Scientist at Amgen from 2000 to 2008. Michael holds a Ph.D. in Pharmaceutical Sciences with a focus on Ocular Physiology, Pharmacology, and Drug Delivery from the University of Southern California, as well as a B.S. in Biological Sciences and Japanese Language and Literature from UC Irvine.